艾司洛尔对全麻诱导时罗库溴铵起效时间及患者血流动力学的影响

目的 探讨围术期应用艾司洛尔对罗库溴铵的起效时间及患者血流动力学的影响.方法 选择2005年2月至9月本院行择期非心脏手术患者60例,随机数字表法分为E组和C组,每组30例.全麻诱导后,E组予以艾司洛尔0.5 mg/kg静脉推注,C组予以10ml生理盐水静脉推注.1 min后,静脉推注罗库溴铵0.6 mg/kg.注入艾司洛尔或生理盐水后6 min进行气管插管.记录全麻诱导前(Tb),予以艾司洛尔或生理盐水前(T0)及予以艾司洛尔或生理盐水后1 min(T1)、2min(T2)、3min(T3)、4 min(T4)、5 min(T5)2组患者血流动力学变化及罗库溴铵起效时间.结果 在T2至T5时点,E组的心率和心输出量均明显低于C组(均P＜0.05).与T0时点比较,T1至T5时点予以艾司洛尔后E组患者的心率、心输出量和平均动脉压明显下降(均P＜0.05).E组的罗库溴铵起效时间较C组明显延长[(120±6)s比(88±4)s,P＜0.001].结论 伴随血压、心率以及心输出量的下降,艾司洛尔明显延长罗库溴铵起效时间.     

老年高血压患者全膝关节置换中硬膜外复合小剂量静脉麻醉的安全性

背景：老年高血压患者常合并器官组织缺血,在接受关节置换的过程中较易出现各种风险。为保证置换手术的顺利进行,提高安全性,需要选择合适的麻醉方式。 目的：探讨硬膜外复合小剂量静脉麻醉在老年高血压全膝关节置换中的应用安全性。 方法：从2013年12月至2014年12月河北医科大学附属第三医院收治的老年高血压关节置换患者中选择64例,随机分为对照组和观察组,每组32例,分别给予全凭静脉麻醉和硬膜外复合小剂量静脉麻醉。测定麻醉前、麻醉诱导后、麻醉后10 min、应用骨水泥后10 min、置换结束时两组患者的收缩压、舒张压、心率、血氧饱和度、呼吸率变化;记录置换中血管活性药物(包括麻黄碱、多巴胺等)的使用率以及置换后不良事件发生情况等。 结果与结论：较之麻醉前,两组患者在麻醉后10 min、应用骨水泥后10 min的收缩压、舒张压均显著降低,血氧饱和度均升高,差异均有显著性意义(P < 0.05);置换结束时对照组收缩压、舒张压及呼吸率显著高于观察组,差异均有显著性意义(P < 0.05)。观察组和对照组使用血管活性药物,包括麻黄碱、多巴胺等的分别有3例和15例,使用率经比较差异有显著性意义(P < 0.05)。且对照组置换后有5例患者出现呼吸功能不全,给予短期呼吸机支持后明显改善。提示与全凭静脉麻醉相比,在老年高血压患者全膝关节置换中实施硬膜外复合小剂量静脉麻醉具有更高的安全性。中国组织工程研究杂志出版内容重点：人工关节;骨植入物;脊柱;骨折;内固定;数字化骨科;组织工程     

下肢静脉区域阻滞用于老年患者单膝关节置换术的临床研究

目的探讨下肢静脉区域阻滞在老年单膝关节置换术中的可行性和安全性。方法选择本院2011年3月~2013年6月择期行单侧膝关节置换术老年患者48例,随机分为全身麻醉(General anesthesia,GA)组(n=24),静脉区域阻滞(Intravenous regional anesthesia,IVRA)组(n=24)。分别记录两组入室诱导前(T0)、气管插管或静脉区域阻滞成功后(T1)、切皮(T2)、截骨(T3)和松止血带10分钟(T4)的收缩压、舒张压和心率。患者感觉神经阻滞的起效时间,阻滞完善时间及维持时间,术后关节活动度,并记录与麻醉相关的不良反应。结果静脉区域阻滞感觉阻滞起效时间为(5.04±1.08)分钟,维持时间(95.46±5.24)分钟。SBP和DBP在T3时心率和血压GA组低于IVRA组(0.05),T4时GA组高于IVRA组(0.05)。IVRA组有7例在截骨时有体动反应,复合静脉用药可完成手术。IVRA组患者术后1周和2周所达到的最大活动度和GA组没有统计学差异(0.05)。IVRA组术后恶心、呕吐和术后高血压发生率低于GA组(0.05)。二组均无麻醉相关并发症。结论静脉区域阻滞用于老年患者单膝关节置换术安全有效,尤其适用于术后接受抗凝治疗以及不适合全身麻醉的老年患者。     

Effects of conventional vs high-dose rocuronium on the QTc interval during anesthesia induction and intubation in patients undergoing coronary artery surgery: a randomized,double-blind,parallel trial

Myocardial ischemia, as well as the induction agents used in anesthesia, may cause corrected QT interval (QTc) prolongation. The objective of this randomized, double-blind trial was to determine the effects of high- vs conventional-dose bolus rocuronium on QTc duration and the incidence of dysrhythmias following anesthesia induction and intubation. Fifty patients about to undergo coronary artery surgery were randomly allocated to receive conventional-dose (0.6 mg/kg, group C, n=25) or high-dose (1.2 mg/kg, group H, n=25) rocuronium after induction with etomidate and fentanyl. QTc, heart rate, and mean arterial pressure were recorded before induction (T0), after induction (T1), after rocuronium (just before laryngoscopy; T2), 2 min after intubation (T3), and 5 min after intubation (T4). The occurrence of dysrhythmias was recorded. In both groups, QTc was significantly longer at T3 than at baseline [475 vs 429 ms in group C (P=0.001), and 459 vs 434 ms in group H (P=0.005)]. The incidence of dysrhythmias in group C (28%) and in group H (24%) was similar. The QTc after high-dose rocuronium was not significantly longer than after conventional-dose rocuronium in patients about to undergo coronary artery surgery who were induced with etomidate and fentanyl. In both groups, compared with baseline, QTc was most prolonged at 2 min after intubation, suggesting that QTc prolongation may be due to the nociceptive stimulus of intubation.     

Comparison of the effects of inhalational and total intravenous anesthesia on quality of recovery in patients undergoing endoscopic transsphenoidal pituitary surgery: a randomized controlled trial

Background: Endoscopic transsphenoidal pituitary surgery has shown promising results. However, fast and high-quality recovery after this procedure remains a challenge for neuroanesthesiologists. This study aimed to compare the quality of recovery after transsphenoidal pituitary surgery between patients who received inhalational anesthesia with sevoflurane and patients who received propofol-based total intravenous anesthesia (TIVA).Methods: Eighty-two patients undergoing transsphenoidal pituitary surgery were randomized to receive either sevoflurane inhalation with manual infusion of remifentanil (sevoflurane group) or effect-site target-controlled infusion of propofol and remifentanil (TIVA group). The primary outcome was the 40-item Quality of Recovery (QoR-40) score on postoperative day 1. The QoR-40 questionnaire was completed by patients the day before surgery and on postoperative days 1 and 2. Emergence agitation and recovery characteristics were also assessed.Results: There were no significant differences between the groups in the global QoR-40 scores on both postoperative days 1 and 2 (difference -8.7, 95% CI -18.0 to 0.7, and P = 0.204; -3.6, 95% CI -13.0 to 5.8, and P > 0.999, respectively). The time to verbal response and time to extubation were significantly shorter in the sevoflurane group than in the TIVA group (P < 0.001 and P < 0.001, respectively). However, the incidence of emergence agitation was lower in the TIVA group than in the sevoflurane group (P < 0.001).Conclusions: Both inhalational anesthesia with sevoflurane and propofol-based TIVA were appropriate anesthetic techniques for patients undergoing endoscopic transsphenoidal pituitary surgery in terms of the quality of recovery up to 2 days postoperatively. Rapid emergence was observed in the sevoflurane group, while smooth emergence was observed in the TIVA group.     

手术与非手术治疗老年性桡骨远端骨折疗效比较

目的比较手术和非手术两种方法治疗老年性桡骨远端骨折的效果。方法对88例年龄65岁的桡骨远端骨折的患者资料进行回顾性分析,经采用不同方法治疗,比较腕关节的功能恢复情况。结果治疗6个月后,采用手术治疗的患者腕关节功能要好于非手术治疗的患者,但1年后两组患者的腕关节功能对比,差异无统计学意义(0.05)。结论早期手术治疗老年性桡骨远端骨折比非手术治疗恢复良好,而1年后对关节功能的恢复无明显差异。     

异丙酚复合瑞芬太尼与七氟烷复合芬太尼对斜视术后麻醉恢复的对比研究

目的 比较异丙酚复合瑞芬太尼与七氟烷复合芬太尼对全麻术后快速动眼运动恢复时间的影响.方法 60例成年患者,随机分为两组,每组30例.R组(异丙酚复合瑞芬太尼)用异丙酚复合瑞芬太尼进行诱导及麻醉维持,S组(七氟烷复合芬太尼)用异丙酚及芬太尼诱导,七氟烷维持麻醉.麻醉停药后开始每2分钟评价麻醉恢复程度.至患者可行快速动眼运动为恢复时间,麻醉恢复后开始进行眼科评价.结果 快速动眼运动平均恢复时间,R组短于S组[(14.72±5.10)min比(23.43±5.52)min,P=0.000],差异有统计学意义.术后S组恶心呕吐发生率高于R组(37%比10%,P=0.037),差异有统计学意义.结论 需要进行即时术后眼科评估的斜视手术中,异丙酚复合瑞芬太尼更有优势.     

Crystalloid and colloid preload for maintaining cardiac output in elderly patients undergoing total hip replacement under spinal anesthesia

The aim of the present study was to compare the effects of colloid and crystalloid preload on cardiac output (CO) and incidence of hypotension in elderly patients under spinal anesthesia (SA). A randomized, double-blinded study was conducted including 47 elderly patients undergoing scheduled total hip replacement (THR), who were randomized to three groups: the control group (C group, n = 15), crystalloid (RS group, n =16) and colloid group (HES group, n = 16). An intravenous preload of 8 mL/kg of either lactated Ringer’s solution in the RS group or 6% hydroxyethyl starch in the HES group was infused within 20 min before SA induction, while no intravenous preload was given in the C group. There was a trend of decrease in CO and systolic blood pressure after SA with time in the C group. In the RS and HES groups, CO increased significantly after fluid preloading as compared with baseline (P < 0.01). Thereafter, CO remained higher than baseline until 30 min after SA in the HES group. The change of systolic blood pressure was similar to CO, but no significant difference from baseline was observed in each group. Hypotension occurred in 3 patients in the C group and one each in the RS and HES group, respec-tively (P = 0.362). Intravascular volume preload with colloid is more effective than crystalloid solution in main-taining CO, which may be improved the hemodynamic stability in elderly patients during SA.     

瑞芬太尼、舒芬太尼全凭静脉麻醉在妇科腹腔镜手术中的应用

目的对比瑞芬太尼或舒芬太尼全凭麻醉应用于妇科腹腔镜手术的麻醉特点。方法选择妇科腹腔镜手术患者80例,分为2组,瑞芬组40例实施全凭瑞芬太尼静脉麻醉,舒芬组40例实施全凭舒芬太尼静脉麻醉,比较2组在诱导前、诱导后、插管、气腹、术毕5个阶段心率、平均动脉压的变化情况,记录2组在苏醒时间、拔管时间、术后24 h疼痛、排气时间及术后并发症等方面的差异。结果患者心率、平均动脉压变化趋势和幅度无明显差别(P0.05),患者苏醒时间、拔管时间瑞芬组优于舒芬组(P0.01),术后24 h疼痛舒芬组较瑞芬组轻(P0.01),排气时间、不良反应无明显差异(P0.05)。结论舒芬太尼和瑞芬太尼用于妇科腹腔镜手术均能取得良好的麻醉效果,两者对血流动力学的影响基本一致,瑞芬太尼在恢复方面优于舒芬太尼,而舒芬太尼具有更强的术后镇痛。     

Narcotrend监测下麻醉深度对老年患者胃肠道肿瘤手术后认知功能障碍的影响

目的:探讨镇静深度监测系统Narcotrend(NT)监测下麻醉深度与局部脑氧饱和度(regional cerebral oxygen saturation, rSO₂)的相关性,及其在预测老年胃肠道肿瘤患者术后认知功能障碍(post-operative cognitive dysfunction, POCD)的价值。方法:按照纳入标准择取2018年6月～2019年6月在安徽医科大学附属安庆医院行胃肠道肿瘤择期手术的老年患者90名,患者术中行NT监测麻醉深度,采用近红外光谱仪持续监测rSO₂。分别采集患者术前1 d、手术结束时和术后24 h的外周血,ELISA法检测血浆中S100β和白细胞介素6(interleukin-6, IL-6)的表达变化。采用简易智力状况检测法(mini-mental state examination, MMSE)评估患者术后24 h的认知功能。结果:术后24 h共有25例患者被诊断为POCD,POCD患者术中Narcotrend指数(Narcotrend index, NTI)<35的时间显著高于非POCD...     

七氟烷和丙泊酚麻醉对肺癌患者围术期细胞因子平衡的影响

目的:探讨七氟烷单纯吸入麻醉和丙泊酚全凭静脉麻醉对肺癌患者围术期细胞因子平衡的影响.方法:选择90例择期开胸行单纯性肺叶切除术的肺癌患者,随机分为两组:A组采用七氟烷单纯吸入麻醉;B组采用丙泊酚全凭静脉麻醉,每组45例.分别于麻醉诱导前即刻(T0)、单肺通气开始前即刻(T1)、单肺通气结束前即刻(T2)、手术关胸后即刻...     

直接前入路和微创后外侧入路人工股骨头置换术治疗高龄股骨颈骨折患者的疗效比较

目的　本研究旨在比较直接前入路（direct anterior approach,DAA）和微创后外侧入路（posterolateral piriformis-sparing approach,Mis-PLA）人工股骨头置换术治疗高龄股骨颈骨折患者的疗效。 方法　44例高龄单侧股骨颈骨折患者按照行人工股骨头置换术入路随机分为DAA组（n =22）和Mis-PLA组（n =22）。2组均完成术后2年随访调查,比较2组患者手术情况、术后早期疼痛及并发症情况、术后早期坐位的能力、弃拐独立行走的时间、术后6周及2年患者功能活动Harris评分及术后2年死亡率。 结果　（1）与Mis-PLA组相比,DAA组患者手术时间较长,术后72 h患肺炎的人数较少,术后24 h VAS评分减低,术后患者可坐位1 h的时间及弃拐独立行走的时间较早（P＜0.05）。（2）术后6周,DAA组在穿袜系鞋带及坐椅子方面Harris评分优于Mis-PLA组（P＜0.05）,两组上楼梯方面Harris评分无统计学差异（P＞0.05）。术后2年,两组患者在功能活动Harris评分均无统计学差异（P＞0.05）。（3）术后随访2年,2组患者死亡率差异无统计学意义（P＞0.05）。 结论　DAA入路股骨头置换术在治疗高龄股骨颈骨折患者中,可以较Mis-PLA入路更有效地降低术后长期卧床的相关并发症的发生率,减轻患者术后疼痛,更早更快地改善患者术后髋关节功能。     

高龄全膝关节置换中全麻和硬膜外麻醉对凝血功能的影响

背景：在行全膝关节置换的高龄患者围手术期,维持正常的凝血功能至关重要。但多种因素会对患者的围手术期凝血功能产生影响,其中麻醉是一重要的因素。不同的麻醉方式会对患者的凝血功能产生不同的影响,临床需要积极的选择适当的麻醉方式以维持稳定的凝血功能。 目的：观察全麻和硬膜外麻醉在高龄全膝关节置换中的应用及对患者凝血功能的影响。 方法：回顾性分析山东省立集团东营医院2012年9月至2013年9月收治的135例行全膝关节置换高龄患者的临床资料,按照麻醉方式分为两组,对照组67例给予全身麻醉,观察组68例给予硬膜外麻醉。观察两组患者麻醉前、麻醉后6 h、置换后第1天清晨的凝血指标和D-二聚体水平变化,随访12个月检测两组深静脉血栓发生情况,并进行比较。 结果与结论：经统计和比较,两组患者在不同时间点的凝血功能各项指标差异均无显著性意义(P均 > 0.05);但两组患者的D-二聚体水平在麻醉后6 h以及置换后第1天清晨差异有显著性意义,观察组显著低于对照组(P均< 0.05);观察组和对照组的置换后深静脉血栓发生率分别为3%和21%,差异有显著性意义(P < 0.05)。表明在高龄全膝关节置换中对患者实施硬膜外麻醉可以获得更好的应用效果,维持稳定的凝血功能状态。中国组织工程研究杂志出版内容重点：人工关节;骨植入物;脊柱;骨折;内固定;数字化骨科;组织工程     

LPFP钢板治疗老年股骨粗隆间骨折29例分析

目的探讨治疗不稳定股骨粗隆间骨折的新方法。方法应用股骨LPFP钢板治疗老年股骨粗隆间骨折29例。结果术后随访4-25月﹙平均10.3月﹚,应用Sanders评分标准:优20例,良6例,一般1例,差2例,优良率89.66%。结论股骨LPFP钢板治疗老年非稳定性股骨粗隆间骨折是内固定的一个很好补充,操作简单,固定可靠。     

老年全髋关节置换术患者隐性失血的风险模型建立和验证

目的 建立老年全髋关节置换术患者隐性失血的风险预测模型,并进行内部验证。方法 选择2020年1月至2022年8月在南充市中心医院行全髋关节置换术的老年患者248例进行回顾性分析。观察可能影响老年全髋关节置换术患者隐性失血的相关因素,以术后隐性失血量480 mL为界值将患者分为两组。比较两组各可能影响老年全髋关节置换术患者隐性失血的相关因素,再以LASSO筛选出可能影响因素后行多因素Logistic回归,根据多因素分析结果建立列线图模型并进行验证。结果 本研究纳入的行全髋关节置换术的老年患者248例中,高隐性失血量组39例,平均失血量为（582.17±76.18） mL;低隐性失血量组209例,平均失血量为（367.19±43.02） mL。经多因素Logistic回归分析结果显示：年龄、高血压、糖尿病、骨质疏松、手术时间、假体类型为老年全髋关节置换术患者隐性失血的独立影响因素（P＜0.05）。根据多因素分析结果建立老年全髋关节置换术患者隐性失血预测列线图模型,ROC曲线分析结果显示,该列线图模型老年全髋关节置换术患者隐性失血的AUC为0.918［95%CI（0.880,0.955）］,校准曲线结果显示,列线图模型预测老年全髋关节置换术患者高隐性失血的概率与实际概率基本吻合,H-L拟合优度检验结果显示,该列线图模型预测概率与实际概率比较,差异无统计学意义（P＞0.05）。决策曲线分析结果显示：当该列线图模型预测老年全髋关节置换术患者隐性失血的概率阈值为0.15 ～ 0.95时,患者的净受益率大于0。结论 老年全髋关节置换术患者隐性失血的发生与年龄、高血压、糖尿病等因素有关,根据上述因素建立的连线图模型用于预测老年全髋关节置换术患者高隐性失血有较高的准确度与区分度。     

股骨近端锁定钢板治疗老年股骨粗隆间骨折

目的探讨治疗不稳定股骨粗隆间骨折的新方法。方法应用股骨近端锁定钢板治疗老年股骨粗隆间骨折23例。结果术后随访1.5~24月(平均11.7月),应用Sanders评分标准:优15例,良6例,一般1例,差1例,优良率91.30%。结论股骨近端锁定钢板治疗老年非稳定性股骨粗隆间骨折是内固定的一个很好补充,操作简单,固定可靠。     

Improving the outcomes of elderly patients with acute myeloid leukemia in a Brazilian University Hospital

OBJECTIVE:

To evaluate the outcomes of acute myeloid leukemia patients who were older than 60 years of age at the time of diagnosis following the implementation of a treatment algorithm based on age, performance status, and cytogenetic results.

METHODS:

We retrospectively compared the results of 31 elderly acute myeloid leukemia patients (median age of 74 years) who were treated according to the new algorithm.

RESULTS:

Fifteen patients with a good performance status and no unfavorable karyotypes were treated with either intensive cytotoxic chemotherapy (<70 years, nine cases) or adapted etoposide, 6-thioguanine and idarubicine (>70 years, six cases); 16 cases with a poor performance status or unfavorable cytogenetics received supportive care only. Six patients achieved a complete remission and two achieved a partial remission after chemotherapy. There were three toxic deaths during induction, two in the adapted etoposide, 6-thioguanine and idarubicine group and one in the intensive cytotoxic chemotherapy group. The overall median survival time was 2.96 months, 1.3 months in the supportive care group, and 4.6 months in the treatment group.

CONCLUSIONS:

Our results illustrate the importance of treatment guidelines adapted to local resources in an attempt to improve the survival of elderly acute myeloid leukemia patients in developing countries.     

The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute

Objectives: We conducted a retrospective study to evaluate the prognostic factors of elderly patients with small cell lung cancer (SCLC). Patients and methods: The records of elderly patients (≥ 65 years) with histologically-proven SCLC were reviewed. The patients’ information including demographic, clinical and laboratory parameters, staging status on the Veterans Administration Lung Study Group staging system, and treatment modalities were registered. Univariate and multivariate survival analysis was performed by the Kaplan-Meier method and Cox proportional hazards model, respectively. Results: Between January 2004 and December 2012, 247 elderly patients with SCLC were analyzed, 129 patients initially presented with limited stage (LS) and 118 with extensive disease (ES). The median age of the patients was 70.7 years (range, 65-83 years). The median follow-up period for all patients was 22.0 months (range, 1.0-84.0 months) and 39.9 months for the surviving patients (range, 4.7-84.0 months). The median survival time (MST) was 17.3 months, and the 2-year and 3-year OS rates were 36.3% and 22.7%, respectively. The MST, 2-year and 3-year OS rates were 22 months, 45.0% and 30.5% in patients with limited stage, versus 13.4 months, 26.5% and 13.7% in patients having extensive diseases, respectively. Multivariate analysis revealed that disease extent (HR = 3.034; P < 0.001) and the number of chemotherapy cycles (HR = 0.486; P = 0.003) were independent prognostic factors for the OS. Additionally, a normal serum NSE level (HR = 0.447, P = 0.017) at the time of diagnosis was independent positive prognostic factors for patients with LS-SCLC, but not for ES-SCLC. Conclusion: Disease extent and the number of chemotherapy cycles were independent prognostic factors of elderly patients with SCLC. The fit cohort might benefit from positive treatment.     

全麻联合硬膜外麻醉对高血压老年患者腹腔镜胆囊切除术患者血流动力学、应激水平的影响

目的：研究全麻联合硬膜外麻醉对高血压老年患者血流动力学、应激水平的影响。方法：选取2014年3月至2015年3月我院接诊的80例行腹腔镜胆囊切除术高血压老年患者作为本次研究对象。按照随机数表法分为观察组和对照组,观察组实施全麻联合硬膜外麻醉,对照组实施单纯全身麻醉,观察两组患者不同时间点血流动力学变化、不同时间点应激水平变化、麻醉苏醒时间比较、不良反应情况。结果：观察组与对照组相比,收缩压(systolic pressure,SBP)、舒张压(diastolic pressure, DBP)、心率(heart rate,HR)明显下降,与T1(手术前)时段比较,对照组各指标在T2(插管时)、T3(手术中)、T4(拔管后)时段有明显的上升,比较差异具有统计学意义(P<0.05);观察组各指标在T2、T3、T4时段略有上升,无统计学意义(P>0.05);观察组患者皮质醇、肾上腺素、內皮素在T2、T3、T4时段低于对照组,差异具有统计学意义(P<0.05);观察组自主呼吸恢复时间、拔管时间、完全清醒时间(4.70±1.02、7.80±2.26、16.29±5.28) min均小于对照组(9.78±3.01、15.83±3.29、28.30±5.22) min,比较差异具有统计学意义(P<0.05);观察组不良反应总发生率7.50%(3/40)小于对照组42.50%(17/40),比较差异具有统计学意义(P<0.05)。结论：全麻联合硬膜外麻醉能够减少高血压老年患者LC患者血流动力学、应激水平的影响,改善患者的预后,提高治疗疗效。     

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score

ObjectiveTo identify predictors of 30-day survival in elderly patients with coronavirus disease 2019 (COVID-19).MethodsRetrospective cohort study including patients with COVID-19 aged ≥65 years hospitalized in six European sites (January 2020 to May 2021). Data on demographics, comorbidities, clinical characteristics, and outcomes were collected. A predictive score (FLAMINCOV) was developed using logistic regression. Regression coefficients were used to calculate the score. External validation was performed in a cohort including elderly patients from a major COVID-19 centre in Israel. Discrimination was evaluated using the area under the receiver operating characteristic curve (AUC) in the derivation and validation cohorts. Survival risk groups based on the score were derived and applied to the validation cohort.ResultsAmong 3010 patients included in the derivation cohort, 30-day survival was 74.5% (2242/3010). The intensive care unit admission rate was 7.6% (228/3010). The model predicting survival included independent functional status (OR, 4.87; 95% CI, 3.93–6.03), a oxygen saturation to fraction of inspired oxygen (SpO₂/FiO₂₎ ratio of >235 (OR, 3.75; 95% CI, 3.04–4.63), a C-reactive protein level of <14 mg/dL (OR, 2.41; 95% CI, 1.91–3.04), a creatinine level of <1.3 (OR, 2.02; 95% CI, 1.62–2.52) mg/dL, and absence of fever (OR, 1.34; 95% CI, 1.09–1.66). The score was validated in 1174 patients. The FLAMINCOV score ranges from 0 to 15 and showed good discrimination in the derivation (AUC, 0.79; 95% CI, 0.77–0.81; p < 0.001) and validation cohorts (AUC, 0.79; 95% CI, 0.76–0.81; p < 0.001). Thirty-day survival ranged from 39.4% (203/515) to 95.3% (634/665) across four risk groups according to score quartiles in the derivation cohort. Similar proportions were observed in the validation set.DiscussionThe FLAMINCOV score identifying elderly with higher or lower chances of survival may allow better triage and management, including intensive care unit admission/exclusion.